225 related articles for article (PubMed ID: 31904914)
1. In vivo monitoring of remnant undifferentiated neural cells following human induced pluripotent stem cell-derived neural stem/progenitor cells transplantation.
Tanimoto Y; Yamasaki T; Nagoshi N; Nishiyama Y; Nori S; Nishimura S; Iida T; Ozaki M; Tsuji O; Ji B; Aoki I; Jinzaki M; Matsumoto M; Fujibayashi Y; Zhang MR; Nakamura M; Okano H
Stem Cells Transl Med; 2020 Apr; 9(4):465-477. PubMed ID: 31904914
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury.
Okubo T; Iwanami A; Kohyama J; Itakura G; Kawabata S; Nishiyama Y; Sugai K; Ozaki M; Iida T; Matsubayashi K; Matsumoto M; Nakamura M; Okano H
Stem Cell Reports; 2016 Oct; 7(4):649-663. PubMed ID: 27666789
[TBL] [Abstract][Full Text] [Related]
3. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity.
Kobayashi Y; Okada Y; Itakura G; Iwai H; Nishimura S; Yasuda A; Nori S; Hikishima K; Konomi T; Fujiyoshi K; Tsuji O; Toyama Y; Yamanaka S; Nakamura M; Okano H
PLoS One; 2012; 7(12):e52787. PubMed ID: 23300777
[TBL] [Abstract][Full Text] [Related]
4. Rehabilitative Training Enhances Therapeutic Effect of Human-iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury.
Shibata T; Tashiro S; Shibata S; Shinozaki M; Shindo T; Hashimoto S; Kawai M; Kitagawa T; Ago K; Matsumoto M; Nakamura M; Okano H; Nagoshi N
Stem Cells Transl Med; 2023 Mar; 12(2):83-96. PubMed ID: 36647673
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the immunogenicity of human iPS cell-derived neural stem/progenitor cells in vitro.
Ozaki M; Iwanami A; Nagoshi N; Kohyama J; Itakura G; Iwai H; Nishimura S; Nishiyama Y; Kawabata S; Sugai K; Iida T; Matsubayashi K; Isoda M; Kashiwagi R; Toyama Y; Matsumoto M; Okano H; Nakamura M
Stem Cell Res; 2017 Mar; 19():128-138. PubMed ID: 28135684
[TBL] [Abstract][Full Text] [Related]
6. Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury.
Kojima K; Miyoshi H; Nagoshi N; Kohyama J; Itakura G; Kawabata S; Ozaki M; Iida T; Sugai K; Ito S; Fukuzawa R; Yasutake K; Renault-Mihara F; Shibata S; Matsumoto M; Nakamura M; Okano H
Stem Cells Transl Med; 2019 Mar; 8(3):260-270. PubMed ID: 30485733
[TBL] [Abstract][Full Text] [Related]
7. Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation.
Itakura G; Kobayashi Y; Nishimura S; Iwai H; Takano M; Iwanami A; Toyama Y; Okano H; Nakamura M
PLoS One; 2015; 10(2):e0116413. PubMed ID: 25706286
[TBL] [Abstract][Full Text] [Related]
8. Long-term selective stimulation of transplanted neural stem/progenitor cells for spinal cord injury improves locomotor function.
Kawai M; Imaizumi K; Ishikawa M; Shibata S; Shinozaki M; Shibata T; Hashimoto S; Kitagawa T; Ago K; Kajikawa K; Shibata R; Kamata Y; Ushiba J; Koga K; Furue H; Matsumoto M; Nakamura M; Nagoshi N; Okano H
Cell Rep; 2021 Nov; 37(8):110019. PubMed ID: 34818559
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic Neural Stem/Progenitor Cells Derived From Embryonic Stem Cells Promote Functional Recovery After Transplantation Into Injured Spinal Cord of Nonhuman Primates.
Iwai H; Shimada H; Nishimura S; Kobayashi Y; Itakura G; Hori K; Hikishima K; Ebise H; Negishi N; Shibata S; Habu S; Toyama Y; Nakamura M; Okano H
Stem Cells Transl Med; 2015 Jul; 4(7):708-19. PubMed ID: 26019226
[TBL] [Abstract][Full Text] [Related]
10. Safe and efficient method for cryopreservation of human induced pluripotent stem cell-derived neural stem and progenitor cells by a programmed freezer with a magnetic field.
Nishiyama Y; Iwanami A; Kohyama J; Itakura G; Kawabata S; Sugai K; Nishimura S; Kashiwagi R; Yasutake K; Isoda M; Matsumoto M; Nakamura M; Okano H
Neurosci Res; 2016 Jun; 107():20-9. PubMed ID: 26804710
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation.
Isoda M; Sanosaka T; Tomooka R; Mabuchi Y; Shinozaki M; Andoh-Noda T; Banno S; Mizota N; Yamaguchi R; Okano H; Kohyama J
Commun Biol; 2023 Jun; 6(1):611. PubMed ID: 37286713
[TBL] [Abstract][Full Text] [Related]
12. LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury.
Ito S; Nagoshi N; Kamata Y; Kojima K; Nori S; Matsumoto M; Takei K; Nakamura M; Okano H
Stem Cell Reports; 2021 Nov; 16(11):2703-2717. PubMed ID: 34653401
[TBL] [Abstract][Full Text] [Related]
13. Whole-Genome DNA Methylation Analyses Revealed Epigenetic Instability in Tumorigenic Human iPS Cell-Derived Neural Stem/Progenitor Cells.
Iida T; Iwanami A; Sanosaka T; Kohyama J; Miyoshi H; Nagoshi N; Kashiwagi R; Toyama Y; Matsumoto M; Nakamura M; Okano H
Stem Cells; 2017 May; 35(5):1316-1327. PubMed ID: 28142229
[TBL] [Abstract][Full Text] [Related]
14. Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord.
Yasuda A; Tsuji O; Shibata S; Nori S; Takano M; Kobayashi Y; Takahashi Y; Fujiyoshi K; Hara CM; Miyawaki A; Okano HJ; Toyama Y; Nakamura M; Okano H
Stem Cells; 2011 Dec; 29(12):1983-94. PubMed ID: 22028197
[TBL] [Abstract][Full Text] [Related]
15. A review of regenerative therapy for spinal cord injury using human iPS cells.
Kawai M; Nagoshi N; Okano H; Nakamura M
N Am Spine Soc J; 2023 Mar; 13():100184. PubMed ID: 36479183
[TBL] [Abstract][Full Text] [Related]
16. Administration of C5a Receptor Antagonist Improves the Efficacy of Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in the Acute Phase of Spinal Cord Injury.
Shibata R; Nagoshi N; Kajikawa K; Ito S; Shibata S; Shindo T; Khazaei M; Nori S; Kohyama J; Fehlings MG; Matsumoto M; Nakamura M; Okano H
J Neurotrauma; 2022 May; 39(9-10):667-682. PubMed ID: 35196890
[TBL] [Abstract][Full Text] [Related]
17. A robust culture system to generate neural progenitors with gliogenic competence from clinically relevant induced pluripotent stem cells for treatment of spinal cord injury.
Kamata Y; Isoda M; Sanosaka T; Shibata R; Ito S; Okubo T; Shinozaki M; Inoue M; Koya I; Shibata S; Shindo T; Matsumoto M; Nakamura M; Okano H; Nagoshi N; Kohyama J
Stem Cells Transl Med; 2021 Mar; 10(3):398-413. PubMed ID: 33226180
[TBL] [Abstract][Full Text] [Related]
18. Effects of the Post-Spinal Cord Injury Microenvironment on the Differentiation Capacity of Human Neural Stem Cells Derived from Induced Pluripotent Stem Cells.
López-Serrano C; Torres-Espín A; Hernández J; Alvarez-Palomo AB; Requena J; Gasull X; Edel MJ; Navarro X
Cell Transplant; 2016 Oct; 25(10):1833-1852. PubMed ID: 27075820
[TBL] [Abstract][Full Text] [Related]
19. Transplantation of neural stem/progenitor cells at different locations in mice with spinal cord injury.
Iwai H; Nori S; Nishimura S; Yasuda A; Takano M; Tsuji O; Fujiyoshi K; Toyama Y; Okano H; Nakamura M
Cell Transplant; 2014; 23(11):1451-64. PubMed ID: 23998989
[TBL] [Abstract][Full Text] [Related]
20. Polarized Macrophages Have Distinct Roles in the Differentiation and Migration of Embryonic Spinal-cord-derived Neural Stem Cells After Grafting to Injured Sites of Spinal Cord.
Zhang K; Zheng J; Bian G; Liu L; Xue Q; Liu F; Yu C; Zhang H; Song B; Chung SK; Ju G; Wang J
Mol Ther; 2015 Jun; 23(6):1077-1091. PubMed ID: 25794051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
